Discordant reprogramming of LPS-stimulated cytokine gene transcription and secretion by macrophages after LPS pretreatment

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 209-214

  West, Michael A ^a,b   Baker, Jeffrey ^a   Bellingham, Janet ^b   Clair, Laurel ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOREGULATION; INHIBITION KINETICS; MACROPHAGE ACTIVATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; SEPSIS; TRANSCRIPTION REGULATION;

EID: 0029978923     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0249     Document Type: Conference Paper

References (45)

1. Beal, A. L., and Cerra, F. B. Multiple organ failure syndrome in the 1990's. JAMA 271: 226, 1994.
2. Glauser, M. P., Heumann, D., Baumgartner, J. D., and Cohen, J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin. Infect. Dis. 18: S205, 1994.
3. Munoz, C., Carlet, J., Fitting, C., Misset, B., Bleriot, J.-P., and Cavaillon, J.-M. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747, 1991.
4. Michie, H. R., and Wilmore, D. W. Sepsis and tumor necrosis factor-bedfellows that cannot be ignored. Ann. Surg. 212: 653, 1990.
5. Nathan, C. F. Secretory products of macrophages. J. Clin. Invest. 79: 319, 1987.
6. Beutler, B., Greenwald, D., and Hulmes, J. D. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316: 552, 1985.
7. Dinarello, C. A. Interleukin-1. Rev. Infect. Dis. 6: 51, 1984.
8. Bogdan, C., and Ding, A. Taxol, a microtubule-stabilizing antineoplastic agent induces expression of tumor necrosis factor-α and interleukin-1 in macrophages. J. Leukocyte Biol. 52: 119, 1992.
9. Tracey, K. J., Lowry, S. F., Fahey, T. J., et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gyn. Obstet. 164: 416, 1987.
10. Fong, Y., Tracey, K. J., Moldawer, L. L., et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170: 1627, 1989.
11. West, M. A., Seatter, S. C., Clair, L., Bellingham, J., and Bennett, T. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kianse activation. J. Leukocyte Biol. S30, 1994.
12. West, M. A., Seatter, S. C., Bellingham, J., and Clair, L. Mechanisms of reprogrammed macrophage endotoxin (LPS) signal transduction after LPS pretreatment. Surgery 118: 220, 1995.
13. Seatter, S. C., Bergren, T., Li, M. H., Bubrick, M. P., and West, M. A. Macrophage endotoxin tolerance: tumor necrosis factor and interleukin-1 regulation by lipopolysaccharide pretreatment. Arch. Surg. 129: 1263, 1994.
14. Seatter, S. C., Li, M. H., Bubrick, M. P., and West, M. A. Endotoxin pretreatment of human monocytes alters subsequent endotoxin-triggered release of inflammatory mediators. Shock 3: 252, 1995.
15. Li, M. H., Seatter, S. C., Manthei, R., Bubrick, M. P., and West, M. A. Macrophage endotoxin tolerance: Effect of TNF or endotoxin pretreatment. J. Surg. Res. 57: 85, 1994.
16. Taffet, S. M., Singhel, K. J., Overholtzer, J. F., and Shurtleff, S. A. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipolysacchride and cyclic AMP. Cell. Immunol. 120: 291, 1989.
17. Mathison, J. C., Virca, G. D., Wolfson, E., Glaser, K., and Ulevitch, R. J. Adaptation of bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J. Clin. Invest. 85: 1108, 1990.
18. Cavaillon, J. M., Pitton, C., and Fitting, C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J. Endotoxin Res. 1: 21, 1994.
19. Virca, G. D., Kim, S. Y., Glaser, K. B., and Ulevitch, R. J. Lipopolysaccharide induces hyporesponsivenessto its own action in RAW 269.7 cells. J. Biol. Chem. 130: 800, 1989.
20. 2, nitric oxide and superoxide by macrophages. J. Trauma 37: 82, 1994.
21. Coffee, K. A., Halushka, P. V., Ashton, S. H., Tempel, G. E., Wise, W. C., and Cook, J. A. Endotoxin tolerance is associated with altered GTP-binding protein function. Am. J. Physiol. 73: 1008, 1992.
22. Hafenrichter, D. G., Roland, C. R., Mangino, M. J., and Flye, M. W. The Kupffer cell in endotoxin tolerance: mechanisms of protection against lethal endotoxemia. Shock 2: 251, 1994.
23. Zhang, X., and Morrison, D. C. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leuk. Biol. 54: 444, 1993.
24. Aggarwal, B. B. Human lymphotoxin. Methods Enzymol. 116: 441, 1985.
25. Chomcyznski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanat-phenol-chloroform extraction. Ann. Biochem. 162: 156, 1987.
26. Melby, P. C., Darnell, B. J., and Tyron, V. V. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J. Immunol. Methods 159: 235, 1993.
27. Ferre, F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Applications 2: 1, 1992.
28. Opisovich, O. A., Fegeding, K. V., Misuno, N. I., et al. Differential action of cycloheximide and activation stimuli on transcription of tumor necrosis factor-α, IL-1β, IL-8, and p53 genes in human monocytes. J. Immunol. 150: 4958, 1993.
29. Zuckerman, S. H., Evans, G. F., and Gutherie, L. Transcriptional and post-translational mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology 73: 460, 1991.
30. West, M. A., Bennet, T., and Clair, L. Reprogrammed macrophage TNF release with inflammatory pretreatment: differential regulation by endotoxin and zymosan. J. Trauma 39: 404, 1995.
31. Zuckerman, S. H., and Evans, G. F. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell. Immunol. 140: 513, 1992.
32. Takasuka, N., Tokunaga, T., and Akagawa, K. S. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J. Immunol. 146: 3824, 1991.
33. Haas, J. G., Thiel, C., Blomer, K., Weiss, E. H., Riethmuller, G., and Ziegler-Heitbrock, H. W. L. Down regulation of tumor necrosis factor expression in the human mono-Mac-6 cell line by lipopoysacchride. J. Leukocyte Biol. 43: 11, 1989.
34. Fahmi, H., and Chaby, R. Desensitization of macrophages to endotoxin effects is not correlated with a down regulation of lipopolysaccharide-binding protein. Cell. Immunol. 150: 219, 1993.
35. Han, J., Brown, T., and Beutler, B. Endotoxin-responsive sequnces control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171: 465, 1990.
36. Knopf, H.-P., Otto, F., Engelhardt, R., et al. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and synthestic lipid A analogue DSZ MRL 953. J. Immunol. 153: 287, 1994.
37. Chen, H., Halushka, P. V., and Cook, J. A. Endotoxin tolerance: effects on lethality and macrophage thromboxane and interleukin-6 production. Shock 1: 366, 1994.
38. Seatter, S. C., Clair, L., Bennett, T., Bubrick, M. P., and West, M. A. Independent signal transduction pathways for IL-1 and TNF in LPS-tolerant macrophages. J. Surg. Res. 58: 651, 1995.
39. Sanguedolce, M.-V., Capo, C., Bouhamdan, M., Bongrand, P., Huang, C.-K., and Mege, J.-L. Zymosan-induced tyrosine phosphorylations in human monocytes. J. Immunol. 151: 405, 1993.
40. Dong, Z., Qi, X., and Fidler, I. J. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural synthetic bacterial products. J. Exp. Med. 177: 1071, 1993.
41. Zuckerman, S. H., Evans, G. F., and Butler, L. D. Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis expression. Infect. Immun. 59: 2774, 1991.
42. Evans, G. F., Snyder, Y. M., Butler, L. D., and Zuckerman, S. H. Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ. Shock 29: 279, 1989.
43. Granowitz, E. V., Porat, R., Mier, J. W., et al. Intravenous endotoxin supresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151: 1637, 1993.
44. Weinstein, S. L., June, C. H., and DeFranco, A. L. Lipopolysacchride-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J. Immunol. 151: 3829, 1993.
45. Liu, M. K., Herrera-Velit, P., Browney, R. W., and Reiner, N. E. CD14-dependent activation of protein kinase C and mitogen-activated kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153: 2642, 1994.